Youfei Guan
Shenyang Pharmaceutical University(CN)North Sichuan Medical University(CN)University of California, San Francisco(US)Dalian Medical University(CN)Peking University(CN)Biomarker Technologies (China)(CN)Weifang People's Hospital(CN)Chengdu Second People's Hospital(CN)Peking University Third Hospital(CN)East China Normal University(CN)
Publications by Year
Research Areas
Inflammatory mediators and NSAID effects, Peroxisome Proliferator-Activated Receptors, Liver Disease Diagnosis and Treatment, Eicosanoids and Hypertension Pharmacology, Cholesterol and Lipid Metabolism
Most-Cited Works
- → Prevention of Obesity and Insulin Resistance in Mice Lacking Plasminogen Activator Inhibitor 1(2004)398 cited
- → Salt–sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor(1999)396 cited
- → Peroxisome proliferator-activated receptors (PPARs): Novel therapeutic targets in renal disease(2001)292 cited
- → Leucine metabolism in regulation of insulin secretion from pancreatic beta cells(2010)232 cited
- → Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans(1997)225 cited
- → Mitochondrial reactive oxygen species promote p65 nuclear translocation mediating high-phosphate-induced vascular calcification in vitro and in vivo(2011)214 cited